Incyte License Agreements
4 Contracts & Agreements
- Letter agreement, dated May 13, 2020, between the Company and Eli Lilly and Company, together with related Letter of Understanding, dated March 5, 2020, between the Company and... (Filed With SEC on August 4, 2020)
- FIRST AMENDMENT TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 4, 2017)
- LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN AGENUS INC., 4-ANTIBODY AG, INCYTE EUROPE SARL, AND INCYTE CORPORATION, SOLELY FOR PURPOSES OF SECTION 12.16 (Filed With SEC on April 30, 2015)
- Confidential Treatment Requested.Confidential portions of this document have been redacted and have been separately filed with the Commission. COLLABORATIVE RESEARCH AND LICENSE... (Filed With SEC on March 3, 2006)
